July 30, 2020 – Premier Inc. (Charlotte, NC) announced a data license agreement with the National Institutes of Health (NIH). The agreement provides researchers in the NIH Clinical Center’s intensive care unit with access to the Premier Healthcare Database (PHD) to investigate the effects of COVID-19 on patients in the United States
Researchers at the NIH Clinical Center – the largest research hospital in America – will use the database’s discharge and microbiology data to investigate the demographic, clinical features, secondary infections, and treatment patterns of COVID-19 patients from more than 800 hospitals across the country. with the aim of better understanding the reasons for different results.
The partnership is not expected to have a material impact on the financial results for the 2021 financial year.
The Premier Hospital Database contains data from more than 1 billion patients (approximately one in five hospitalizations in the United States).
According to Premier, all patient-related data are not identified in the database and are HIPAA compliant, both in inpatient and hospital-related outpatient settings, including demographic and disease status, as well as information about services billed, including medication, laboratory tests and diagnoses performed, and therapeutic services. Information about hospital characteristics, including geographic location, bed size and class status, is also included.
Premier’s research department, Premier Applied Sciences, recently published a white paper describing the properties and capabilities of the PhD in relation to COVID-19 data.
Note: We are not the author of this content. For the Authentic and complete version,
Check its Original Source